Solesence Inc

Following a post-capitulation volatility contraction and lower wick absorption since mid-July, price is stabilizing at the capitulation low. With Mean Reversion eligibility and a flattened EMA regime, the medium-term bias is Bullish, but short-term timing remains Neutral awaiting evidence of support holding. Stalk around the absorption-support zone for a potential mean-reversion bounce.

• ↑Order backlog at $64.9M implies robust revenue pipeline and underpins management’s double-digit growth target.
• ↑Management forecasts ~$35M in H2 2026 sales, marking the strongest half-year in company history.
• ↓Q2 2026 revenue dropped 25% YoY to $15.3M, eroding top-line momentum.